CLINICAL_TRIALS
trial_result
· 2017-12-29
Clinical Trial Update: Study of Anlotinib in Patients With Gastric Cancer(ALTER0503) [Phase 2, Phase 3]
Summary
Clinical trial update for Anlotinib in gastric cancer (ALTER0503) spanning Phase 2 and Phase 3.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Conditions: Gastric Cancer | Phase 2, Phase 3 | Status: UNKNOWN